CHI Advisors as of June 30, 2022
Portfolio Holdings for CHI Advisors
CHI Advisors holds 26 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prometheus Biosciences | 18.0 | $47M | 1.7M | 28.23 | |
| Cullinan Oncology (CGEM) | 14.9 | $39M | 3.0M | 12.82 | |
| Repare Therapeutics Ord (RPTX) | 14.1 | $37M | 2.6M | 13.99 | |
| Pliant Therapeutics (PLRX) | 9.5 | $25M | 3.1M | 8.01 | |
| Vectivbio Hldg Ord Shs | 7.8 | $20M | 3.8M | 5.40 | |
| Kezar Life Sciences | 6.1 | $16M | 1.9M | 8.27 | |
| 2seventy Bio Common Stock | 4.1 | $11M | 820k | 13.20 | |
| Inozyme Pharma (INZY) | 3.7 | $9.7M | 2.0M | 4.77 | |
| Compass Therapeutics (CMPX) | 2.9 | $7.5M | 2.8M | 2.65 | |
| Ikena Oncology (IKNA) | 1.8 | $4.8M | 1.1M | 4.43 | |
| Precision Biosciences Ord | 1.8 | $4.8M | 3.0M | 1.60 | |
| Nkarta (NKTX) | 1.7 | $4.4M | 358k | 12.32 | |
| Freeline Therapeutics Hldgs Sponsored Ads | 1.6 | $4.2M | 4.9M | 0.87 | |
| Omega Therapeutics Common Stock (OMGAQ) | 1.5 | $4.0M | 1.1M | 3.80 | |
| Akouos | 1.5 | $3.9M | 836k | 4.69 | |
| G1 Therapeutics | 1.4 | $3.8M | 767k | 4.94 | |
| Orchard Therapeutics Ads | 1.2 | $3.1M | 5.3M | 0.58 | |
| Oncorus | 1.1 | $3.0M | 2.4M | 1.26 | |
| Larimar Therapeutics (LRMR) | 1.1 | $3.0M | 1.5M | 1.96 | |
| Keros Therapeutics (KROS) | 1.1 | $2.9M | 103k | 27.63 | |
| Corvus Pharmaceuticals (CRVS) | 0.8 | $2.2M | 2.2M | 0.99 | |
| Entrada Therapeutics (TRDA) | 0.8 | $2.0M | 164k | 12.18 | |
| Ovid Therapeutics (OVID) | 0.7 | $1.9M | 865k | 2.15 | |
| Eiger Biopharmaceuticals | 0.5 | $1.4M | 215k | 6.30 | |
| Phasebio Pharmaceuticals | 0.2 | $450k | 750k | 0.60 | |
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 0.1 | $372k | 157k | 2.37 |
